Inhibition of angiogenic activity of renal carcinoma by an antisense oligonucleotide targeting fibroblast growth factor-2

Anticancer Research

Volumn 25, Issue 2 A, 2005, Pages 1109-1113

  Cenni, Elisabetta ^a   Perut, Francesca ^a   Zuntini, Monia ^a   Granchi, Donatella ^a   Amato, Ilaria ^a   Avnet, Sofia ^a   Brandi, Maria Luisa ^c   Giunti, Armando ^a,b   Baldini, Nicola ^a,b  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b University of Florence ^*  (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Angiogenesis; Antisense oligodeoxynucleotide; Bone metastasis; Fibroblast growth factor 2; Renal cell carcinoma

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; ANTISENSE PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDE; FIBROBLAST GROWTH FACTOR 2; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; BONE METASTASIS; CANCER INHIBITION; CELL ISOLATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA TRANSFECTION; DRUG TARGETING; ENDOTHELIUM CELL; EVALUATION; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; NUCLEOTIDE METABOLISM; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

BLOTTING, WESTERN; CARCINOMA, RENAL CELL; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CHEMOTAXIS; ENDOTHELIAL CELLS; FIBROBLAST GROWTH FACTOR 2; HUMANS; KIDNEY NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; OLIGONUCLEOTIDES, ANTISENSE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION;

EID: 17444373925     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Slaton JW, Inoue K, Perrotte P, El-Naggar AK, Swanson DA, Fidler IJ and Dinney CPN: Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renal cell carcinoma. Am J Pathol 158: 735-743, 2001.
2. Rasmuson T, Grankvist K, Jacobsen J and Ljungberg B: Impact of serum basic fibroblast growth factor on prognosis in human renal cell carcinoma. Eur J Cancer 37: 2199-2203, 2001.
3. Prats H, Kaghad M, Prats AC, Klagsbrun M, Lelias JM, Liauzun P, Chalon P, Tauber JP, Amalric F, Smith JA et al: High molecular mass forms of basic fibroblast growth factor are initiated by alternative CUG codons. Proc Natl Acad Sci USA 86: 1836-1840, 1989.
4. Florkiewicz RZ and Sommer A: Human basic fibroblast growth factor encodes four polipeptides, three initiate from non-AUG codons. Proc Natl Acad Sci USA 86: 3979-3981, 1989.
5. Avnet S, Cenni E, Granchi D, Perut F, Amato I, Battistelli L, Brandi ML, Giunti A and Baldini N: Isolation and characterization of a new cell line from a renal carcinoma bone metastasis. Anticancer Res 24: 1705-1711, 2004.
6. Streeten EA, Ornberg R, Curcio F, Sakaguchi K, Marx S, Aurbach GD and Brandi ML: Cloned endothelial cells from fetal bovine bone. Proc Natl Acad Sci USA 86: 916-920, 1989.
7. Morrison RS: Suppression of basic fibroblast growth factor expression by antisense oligodeoxynucleotides inhibits the growth of transformed human astrocytes. J Biol Chem 266: 728-734, 1991.
8. Netzer P, Domek M, Pai R, Halter F and Tarnawski A: Inhibition of human colon cancer cell growth by antisense oligodeoxynucleotides targeted at basic fibroblast growth factor. Aliment Pharmacol Ther 15: 1673-1679, 2001.
9. Wang Y and Becker D: Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth. Nat Med 3: 887-893, 1997.
10. Auguste P, Gursel DB, Lemière S, Reimers D, Cuevas P, Carceller F, Di Santo JP and Bikfalvi A: Inhibition of fibroblast growth factor/fibroblast growth factor receptor activity in glioma cells impedes tumor growth by both angiogenesis-dependent and -independent mechanisms. Cancer Res 61: 1717-1726, 2001.